Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal early-onset sepsis: A changing paradigm of pathogens and high-risk cohorts.

Seminars in perinatology·2026
Same author

Neonatal Sepsis from 2014 to 2024: The Resurgence of Gram-Negative Rods.

The Journal of pediatrics·2026
Same author

Correction: A novel and accurate method for estimating umbilical arterial and venous catheter insertion length.

Journal of perinatology : official journal of the California Perinatal Association·2024
Same author

The diagnostic utility of obtaining two blood cultures for the diagnosis of early onset sepsis in neonates.

Journal of perinatology : official journal of the California Perinatal Association·2024
Same author

Reducing MRSA Infection in a New NICU During the COVID-19 Pandemic.

Pediatrics·2023
Same author

A novel and accurate method for estimating umbilical arterial and venous catheter insertion length.

Journal of perinatology : official journal of the California Perinatal Association·2021

Related Experiment Video

Updated: Jul 4, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

Necrotizing enterocolitis in newborns: pathogenesis, prevention and management.

Alecia M Thompson1, Matthew J Bizzarro

  • 1Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520-8064, USA.

Drugs
|June 13, 2008
PubMed
Summary

Necrotizing enterocolitis (NEC) is a serious gastrointestinal disease in premature infants. Prophylactic probiotics show promise in preventing NEC, but more research is needed to confirm their effectiveness.

More Related Videos

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling
09:13

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Related Experiment Videos

Last Updated: Jul 4, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling
09:13

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Area of Science:

  • Neonatal Medicine
  • Gastroenterology
  • Pediatric Surgery

Background:

  • Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in premature neonates, affecting 1-5% of NICU admissions.
  • The exact cause of NEC is unknown, but potential factors include feeding practices, gut bacteria, and mucosal damage.
  • Clinical signs range from vague symptoms like apnea and lethargy to specific GI issues like abdominal distention and bloody stools.

Purpose of the Study:

  • To review the current understanding of NEC's etiology, clinical manifestations, and treatment strategies.
  • To explore potential preventative measures for NEC in premature infants.
  • To highlight the emerging role of probiotics in NEC prevention.

Main Methods:

  • Literature review of NEC research, focusing on contributing factors, clinical presentation, and therapeutic interventions.
  • Analysis of current and investigational preventative strategies, including antenatal corticosteroids, feeding protocols, and novel therapies.
  • Evaluation of recent data on the prophylactic use of probiotics for NEC prevention.

Main Results:

  • NEC is a multifactorial disease with elusive etiology, despite numerous proposed contributing factors.
  • Medical management involves bowel rest, antibiotics, and supportive care, with surgery reserved for refractory cases or complications.
  • Current preventative strategies include antenatal steroids and optimized enteral feeding, with probiotics showing recent promise.

Conclusions:

  • Despite advances, NEC remains a significant threat to premature infants, necessitating effective prevention strategies.
  • Prophylactic probiotic use is a promising avenue for NEC prevention, warranting further large-scale studies.
  • Continued research into NEC's complex etiology and prevention is crucial for improving outcomes in high-risk neonates.